Search for: "AMGEN INC."
Results 301 - 320
of 704
Sorted by Relevance
|
Sort by Date
15 Nov 2012, 11:56 am
Biotech firm Amgen Inc. is combating claims that alleged misstatements it made about two of its anemia medications artificially inflated its stock price. [read post]
1 May 2017, 4:10 am
Last week, the court heard oral argument in Amgen Inc. v. [read post]
16 May 2022, 12:16 pm
Qualcomm Incorporated (licensee appellate standing) and Amgen Inc. v. [read post]
22 Sep 2022, 4:31 am
Gov’t CVSG Brief in Amgen Inc. v. [read post]
22 Nov 2013, 11:50 am
But earlier this year, in Amgen, Inc. v. [read post]
3 Mar 2012, 6:57 pm
In Re: Micromet, Inc. [read post]
18 Mar 2016, 7:47 am
" Amgen Inc. et al v. [read post]
1 Mar 2013, 6:29 am
On February 27, 2013, in a 6-3 decision, the Supreme Court of the United States held in Amgen Inc. v. [read post]
12 Aug 2014, 2:45 pm
" ______________________________________________________________________________ Relevant to the three case reports are these so-called "Dear Doctor" letters sent in late 2012 by the drug company that sells Prolia in the US and Canada to healthcare providers warning them about the risk of atypical or unusual thigh bone / femur fractures is patients using Prolia (denosumab): 9/12/12 Amgen "Dear Doctor" Letter in US: Serious risks… [read post]
13 May 2010, 4:44 pm
Wisconsin has previously settled with Baxter Healthcare Corp. for $1.05 million, and with Amgen Inc. and Immunex for a total of $2 million. [read post]
20 Mar 2008, 8:18 am
In Amgen Inc. v. [read post]
2 May 2021, 1:41 pm
PatentlyOreported on the case of Amgen Inc. v. [read post]
6 Oct 2008, 6:15 am
Del. has granted Ariad leave for immediate appeal to the CAFC of the adverse summary judgment ruling.The Boston Globe noted: Ariad Pharmaceuticals Inc. of Cambridge said today [Oct. 6] that a federal judge has granted its request to permit an immediate appeal of the court's ruling against Ariad in a patent infringement case.In its summary judgment ruling, the US District Court for the District of Delaware found that the administration of Enbrel, a drug marketed by Amgen… [read post]
8 May 2020, 6:57 pm
Supp. 3d at 346.(...)in Amgen Inc. v. [read post]
3 Dec 2008, 8:27 am
The court distinguished Amgen Inc. on the grounds that the non-party in that case did not challenge the arbitrator’s authority to compel prehearing discovery. [read post]
26 Apr 2024, 12:41 pm
by Dennis Crouch I was rereading the Supreme Court’s recent enablement decision of Amgen Inc. v. [read post]
30 Dec 2012, 3:30 am
Patent Litigation Settlement RoundupOn November 8, 2012, Mylan Inc. [read post]
10 May 2013, 6:00 am
Noah Levine, who represented the defendant in Amgen Inc. v. [read post]
12 Jun 2017, 3:18 pm
Amgen Inc. and Bachem in Greener Reaction Conditions - Green Process for Commercial Manufacture of Etelcalcetide Enabled by Improved Technology for Solid Phase Peptide Synthesis Amgen Inc. worked with Bachem to improve the manufacturing process for the active ingredient in ParsabivTM, a drug that treats secondary hyperparathyroidism in adult patients with chronic kidney disease. [read post]
27 Nov 2006, 5:18 am
Amgen v. [read post]
